60% of the way through the buyback - still 34 trading days left on the current program (assuming they stay active right through December). On current run rate will get the $100 M away by the end of the year.
And still the PCA coverage was 2.02 x as of 30 September even after paying the 12 c dividend (~$ 45.2 M) and buying $27.6 M in the buyback during Q3. Assuming the full $100 M is completed before year end - it's a similar capital management spend this quarter ~ $73.4 M
I note there were still some investment losses in the Q3 GIILS report, I'm assuming more mark-to-market losses with higher running yields. As the investment portfolio matures, and future upwards interest rate movements slow, we will see a contribution to the capital base (both technical and shareholder) that could see a large intra quarter jump in PCA coverage.
We're running to stand still on capital management, I think something beyond the current buyback will be announced before the end of the year.
- Forums
- ASX - By Stock
- HLI
- Ann: Update - Notification of buy-back - GMA
Ann: Update - Notification of buy-back - GMA, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLI (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.39 |
Change
-0.020(0.45%) |
Mkt cap ! $1.215B |
Open | High | Low | Value | Volume |
$4.41 | $4.43 | $4.37 | $4.289M | 974.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 26779 | $4.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.40 | 9862 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 26779 | 4.380 |
5 | 22992 | 4.370 |
2 | 15402 | 4.360 |
3 | 38390 | 4.350 |
2 | 33409 | 4.330 |
Price($) | Vol. | No. |
---|---|---|
4.400 | 9862 | 1 |
4.410 | 3936 | 1 |
4.420 | 103533 | 7 |
4.430 | 23716 | 3 |
4.440 | 100 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
HLI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online